S&P 500

5.464,62

0,00%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Nkarta Inc (NKTX)
Nkarta Inc (NKTX) Notícias

NKTX

Nkarta (NKTX)

Nkarta Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:NKTX

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/06/2024	17:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKTX	Nkarta Inc
14/06/2024	17:04	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:NKTX	Nkarta Inc
13/06/2024	17:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKTX	Nkarta Inc
13/06/2024	17:01	GlobeNewswire Inc.	Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors	NASDAQ:NKTX	Nkarta Inc
09/05/2024	17:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NKTX	Nkarta Inc
09/05/2024	17:01	GlobeNewswire Inc.	Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:NKTX	Nkarta Inc
03/04/2024	17:02	GlobeNewswire Inc.	Nkarta to Participate in Upcoming Investor Conferences	NASDAQ:NKTX	Nkarta Inc
25/03/2024	07:30	GlobeNewswire Inc.	Nkarta Announces Pricing of $240 Million Underwritten Offering	NASDAQ:NKTX	Nkarta Inc
21/03/2024	17:01	GlobeNewswire Inc.	Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights	NASDAQ:NKTX	Nkarta Inc
01/03/2024	18:32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NKTX	Nkarta Inc
09/02/2024	08:38	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NKTX	Nkarta Inc
03/01/2024	18:15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NKTX	Nkarta Inc
09/12/2023	22:31	GlobeNewswire Inc.	Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition	NASDAQ:NKTX	Nkarta Inc
13/11/2023	10:25	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NKTX	Nkarta Inc
09/11/2023	18:02	GlobeNewswire Inc.	Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights	NASDAQ:NKTX	Nkarta Inc
07/11/2023	10:02	GlobeNewswire Inc.	Nkarta to Participate at Upcoming Investor Conferences	NASDAQ:NKTX	Nkarta Inc
27/10/2023	17:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NKTX	Nkarta Inc
17/10/2023	13:00	Dow Jones News	Nkarta's Stock Climbs 28% After FDA Approves Drug Application	NASDAQ:NKTX	Nkarta Inc
17/10/2023	12:47	PR Newswire (US)	Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis	NASDAQ:NKTX	Nkarta Inc
17/10/2023	08:01	GlobeNewswire Inc.	Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis	NASDAQ:NKTX	Nkarta Inc
16/10/2023	17:01	GlobeNewswire Inc.	Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures	NASDAQ:NKTX	Nkarta Inc
10/08/2023	08:01	GlobeNewswire Inc.	Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights	NASDAQ:NKTX	Nkarta Inc
03/08/2023	09:02	GlobeNewswire Inc.	Nkarta to Participate at Upcoming Investor Conference	NASDAQ:NKTX	Nkarta Inc
05/07/2023	17:02	GlobeNewswire Inc.	Nkarta Appoints Alyssa Levin Chief Financial and Business Officer	NASDAQ:NKTX	Nkarta Inc
27/06/2023	08:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NKTX	Nkarta Inc
27/06/2023	08:01	GlobeNewswire Inc.	Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia	NASDAQ:NKTX	Nkarta Inc
26/06/2023	17:01	GlobeNewswire Inc.	Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX101 NK Cell Therapy Program	NASDAQ:NKTX	Nkarta Inc
22/06/2023	17:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NKTX	Nkarta Inc
10/06/2023	11:47	GlobeNewswire Inc.	Nkarta Presents NKX019 Clinical Data at the European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma	NASDAQ:NKTX	Nkarta Inc
11/05/2023	17:20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NKTX	Nkarta Inc